As part of a risk management plan, Cipla will provide training on the use of the drug, informed patient consent documents, conduct post-marketing surveillance as well as to conduct a Phase IV clinical trial on Indian patients.
from India Infoline News Service https://ift.tt/3do99Mm
No comments:
Post a Comment